Originally recognized for its vibrant blue color, it quickly transitioned to a valuable therapeutic agent
Indeed, sustained weight reduction of 15% or more in patients with type 2 diabetes may induce remission in a large proportion of subjects and improve metabolic status in the remaining patients [5]
Semaglutide may cause serious side effects, including: Possible thyroid tumors, including cancer
Neurological signs include numbness, trouble walking, and balance issues
Our current offerings include: Compounded Semaglutide Oral Semaglutide Ozempic (branded semaglutide, FDA-approved for type 2 diabetes with off-label weight loss use for eligible patients) Compounded Tirzepatide Oral Tirzepatide Mounjaro (branded tirzepatide, FDA-approved for type 2 diabetes) Zepbound (branded tirzepatide, FDA-approved for chronic weight management) Wegovy (branded semaglutide, FDA-approved for chronic weight management) It is crucial to understand that for these prescription medications, users must complete our free assessment quiz to determine their eligibility and receive a personalized treatment plan from a licensed healthcare provider
.png)
